BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14970226)

  • 1. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3.
    Su SV; Hong P; Baik S; Negrete OA; Gurney KB; Lee B
    J Biol Chem; 2004 Apr; 279(18):19122-32. PubMed ID: 14970226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.
    Hong PW; Flummerfelt KB; de Parseval A; Gurney K; Elder JH; Lee B
    J Virol; 2002 Dec; 76(24):12855-65. PubMed ID: 12438611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
    Hong PW; Nguyen S; Young S; Su SV; Lee B
    J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN).
    Hong P; Ninonuevo MR; Lee B; Lebrilla C; Bode L
    Br J Nutr; 2009 Feb; 101(4):482-6. PubMed ID: 19230080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
    Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional CD4-DC-SIGN fusion proteins demonstrate enhanced avidity to gp120 and inhibit HIV-1 infection and dissemination.
    Du T; Hu K; Yang J; Jin J; Li C; Stieh D; Griffin GE; Shattock RJ; Hu Q
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4640-9. PubMed ID: 22687513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
    Snyder GA; Ford J; Torabi-Parizi P; Arthos JA; Schuck P; Colonna M; Sun PD
    J Virol; 2005 Apr; 79(8):4589-98. PubMed ID: 15795245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
    Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1.
    Geijtenbeek TB; van Duijnhoven GC; van Vliet SJ; Krieger E; Vriend G; Figdor CG; van Kooyk Y
    J Biol Chem; 2002 Mar; 277(13):11314-20. PubMed ID: 11799126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells.
    Azad AK; Torrelles JB; Schlesinger LS
    J Leukoc Biol; 2008 Dec; 84(6):1594-603. PubMed ID: 18772280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution NMR analyses of the C-type carbohydrate recognition domain of DC-SIGNR protein reveal different binding modes for HIV-derived oligosaccharides and smaller glycan fragments.
    Probert F; Whittaker SB; Crispin M; Mitchell DA; Dixon AM
    J Biol Chem; 2013 Aug; 288(31):22745-57. PubMed ID: 23788638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
    Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.
    Arnáiz B; Martínez-Ávila O; Falcon-Perez JM; Penadés S
    Bioconjug Chem; 2012 Apr; 23(4):814-25. PubMed ID: 22433013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding.
    Tabarani G; Reina JJ; Ebel C; Vivès C; Lortat-Jacob H; Rojo J; Fieschi F
    FEBS Lett; 2006 May; 580(10):2402-8. PubMed ID: 16616922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes.
    Colmenares M; Puig-Kröger A; Pello OM; Corbí AL; Rivas L
    J Biol Chem; 2002 Sep; 277(39):36766-9. PubMed ID: 12122001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.